Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Immunosuppressive therapy with azathioprine and prednisone led to central vein phlebitis and occlusion in a renal transplant patient. The condition progressed to liver failure despite medication changes, highlighting potential drug-induced veno-occlusive disease.
Area Of Science
- Nephrology
- Hepatology
- Immunology
Background
- Renal transplantation requires immunosuppressive therapy to prevent organ rejection.
- Azathioprine and prednisone are common immunosuppressants used post-transplantation.
- Veno-occlusive disease (VOD) of the liver is a serious complication that can occur in various clinical settings.
Observation
- A renal transplant recipient on azathioprine and prednisone developed central vein phlebitis and occlusion.
- Liver disease manifested one year post-transplant and progressed rapidly.
- Hepatocellular failure ensued despite switching immunosuppression from azathioprine to cyclophosphamide.
Findings
- The patient's clinical course suggests a potential link between immunosuppressive therapy and the development of veno-occlusive disease.
- Central vein phlebitis and occlusion are key pathological findings.
- The progression to liver failure indicates severe hepatic vascular compromise.
Implications
- This case highlights the importance of monitoring for hepatic complications in transplant patients receiving immunosuppressants.
- Further investigation into the specific mechanisms by which azathioprine and prednisone may induce VOD is warranted.
- Consideration of alternative immunosuppressive strategies or early intervention may be crucial for patients at risk.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.